Pressure
BioSciences,
Inc. to
Discuss
Third
Quarter
2020
Financial Results and
Provide Business Update
Conference
Call
Scheduled for
Tuesday,
November
17th
at 4:30pm
ET
South
Easton,
MA,
November
16,
2019 --
InvestorsHub NewsWire -- Pressure BioSciences, Inc.
(OTCQB:
PBIO) ("PBI"
and
the
"Company")
today
announced
that
the
Company will host a
teleconference to discuss its Third
Quarter
2020
financial results
and to
provide
a business update.
Anyone
interested may listen to the teleconference either live
(by telephone)
or
through
a replay
(by
telephone or via a link
on the Company's website)
approximately one
day after the teleconference.
The
teleconference will include a Company presentation
followed by a Question
& Answer
period. Date: Tuesday,
November
17,
2020. Time:
4:30
PM
Eastern
Time
(ET).
To
attend this teleconference,
live
by telephone:
Dial-in:
(877)
407-8033
(North
America);
(201)
689-8033
(International).
Verbal
Passcode:
PBI
Third
Quarter
2020
Financial
Call
&
Business Update.
For
those
unable
to
participate in the live teleconference, a replay will be
available
beginning
Wednesday,
November
18,
2020.
The replay will be
accessible
via
telephone
and the Company's
website for
30
days.
Replay
Number: (877)
481-4010
(North America);
(919)
882-2331
(Int'l);
Replay
Passcode:
38901.
About
Pressure BioSciences, Inc.
Pressure
BioSciences,
Inc.
(OTCQB:
PBIO)
is
a
leader
in
the
development
and
sale
of
innovative,
broadly
enabling,
pressure-based
solutions
for
the
worldwide
life
sciences
and
other
industries.
Our
products
are
based
on
the
unique
properties
of
both
constant
(i.e.,
static)
and
alternating
(i.e.,
pressure
cycling
technology,
or
PCT)
hydrostatic
pressure.
PCT
is a
patented
enabling
technology
platform
that
uses
alternating
cycles
of hydrostatic
pressure
between
ambient
and
ultra-high
levels
to
control
biomolecular
interactions
safely and reproducibly (e.g.,
cell
lysis,
biomolecule
extraction).
Our
primary
focus
is
in
the
development
of
PCT-based
products
for
biomarker
and
target
discovery,
drug
design
and
development,
biotherapeutics
characterization
and
quality
control,
soil
&
plant
biology,
forensics,
and
counter-bioterror
applications.
Additionally,
major
new
market
opportunities
have
emerged
in
the
use
of
our
pressure-based
technologies
in
the
following
areas:
(1)
the
use
of
our
recently
acquired,
patented
technology
from
BaroFold,
Inc.
(the
"BaroFold"
technology)
to
allow
entry
into
the
bio-pharma
contract
services
sector,
and
(2)
the
use
of
our
recently-patented,
scalable,
high-efficiency,
pressure-based
Ultra
Shear
Technology
("UST")
platform
to
(i)
create
stable
nanoemulsions
of
otherwise
immiscible
fluids
(e.g.,
oils
and
water)
and
to
(ii)
prepare
higher
quality,
homogenized,
extended
shelf-life
or
room
temperature
stable
low-acid
liquid
foods
that
cannot
be
effectively
preserved
using
existing
non-thermal
technologies.
For
more information about PBI and this press release,
please click on the following link: http://www.pressurebiosciences.com
Please visit us on Facebook, LinkedIn, and
Twitter.
